170683 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Sub-classes:COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
#2PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MALIGNANT BREAST CANCER
#3IDENTIFICATION AND QUANTITATION OF HETERODIMERS IN MAB THERAPEUTICS
#4RAPID MULTIPLEXED ANALYSIS OF RELEASED GLYCANS BY DUAL-STAGE MICROFLUIDIC CAPTURE AND PARALLEL FLUORESCENT TAGGING PRIOR TO LC ANALYSIS
#5METHOD OF DETECTING A MICROORGANISM HAVING HIPPURICASE ACTIVITY
#6METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY
#7BIOMARKERS FOR SEVERITY OF ISCHEMIC STROKE AND USE THEREOF
#8Methylcytosine-Selective Deaminases and Uses Thereof
#9DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS
#10AUTOMATION-ENABLED METHODS FOR CHARACTERIZING NON-CONSENSUS N- AND O-GLYCANS IN PROTEINS
#11DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES
#12CANCER RISK ASSESSMENT
#13Method For Fractionation Of Biomolecules
#14Ultrasensitive Label-Free Profiling of Glycans Released from Single Cells
#15NATIVE MICROFLUIDIC CE-MS ANALYSIS OF ANTIBODY CHARGE HETEROGENEITY
#16METHODS AND COMPOSITIONS FOR SIRT1 EXPRESSION AS A MARKER FOR ENDOMETRIOSIS AND SUBFERTILITY
#17METHODS FOR THE QUANTIFICATION OF GLYCOPROTEINS
#18Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
#19METHODS TO IMPROVE DETECTION OF GLYCOSYLAMINES
#20Agents and methods for treating pancreatic ductal adenocarcinomas
#21METHODS FOR THE DESIGN OF NONALLOSTERIC SIRTUIN ACTIVATING COMPOUNDS
#22Compositions and methods for profiling of gut microbiota-associated bile salt hydrolase (BSH) activity
#23INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1
#24ENZYME COUPLED ASSAY FOR QUANTIFICATION OF PROTEIN AND PEPTIDE BINDING BY SAMDI MASS SPECTROMETRY
#25AGENTS AND METHODS FOR TREATING PANCREATIC DUCTAL ADENOCARCINOMAS
#26METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#27ENZYME COUPLED ASSAY FOR QUANTIFICATION OF PROTEIN AND PEPTIDE BINDING BY SAMDI MASS SPECTROMETRY
#28DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS
#29Methods for the design of mechanism-based sirtuin activating compounds
#30DNAzyme-based sensor for
#31Quantitative acetaminophen analytics
#32Compounds and methods for detection of enzymes that remove methyl succinyl groups from epsilon-amino lysine moieties
#33Inhibitors of kidney-type glutaminase, GLS-1
#34HDAC1/2 activator for promoting and/or accelerating myelination and/or remyelination
#35Methods and compositions for SIRT1 expression as a marker for endometriosis and subfertility
#36COMPOSITIONS AND METHODS USING AN EPIGENETIC INHIBITOR
#37ACETAMINOPHEN ASSAY
#38Compounds and methods for detection of enzymes that remove formyl, succinyl, methyl succinyl or myristoyl groups from epsilon-amino lysine moieties
#39METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
#40Blood biomarker for use in evaluation of effect of drug therapy on kidney cancer
#41Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
#42Methods for the design of mechanism-based sirtuin activating compounds
#43Compounds and methods for detection of enzymes that remove formyl, succinyl, methyl succinyl or myristoyl groups from epsilon-amino lysine moieties
#44TREATMENT OF NEURODEGENERATIVE CONDITIONS USING PKC ACTIVATORS AFTER DETERMINING THE PRESENCE OF THE APOE4 ALLELE
#45Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
#46Fluorescent substrates for determining lysine modifying enzyme activity
#47Agents and methods for treating pancreatic ductal adenocarcinomas
#48Nanopatterned extracellular matrices enable cell-based assays with a mass spectrometric readout
#49Attractin and lumican biomarkers in idiopathic pneumonia syndrome
#50Compounds, substrates and methods related to histone deacetylases
#51Inhibitors of kidney-type glutaminase, GLS-1
#52Compounds and methods for detection of enzymes that remove formyl, succinyl, methyl succinyl or myristoyl groups from epsilon-amino lysine moieties
#53PHARMACODYNAMIC ASSAYS
#54METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#55Electrochemical methods and devices for amending urine samples for immunosensor detection
#56Method for determining site having N-linked sugar chain added thereto or proportion of said addition
#57MICROFLUIDIC HPLC-CHIP FOR GLYCOPEPTIDE ANALYSIS WITH INTEGRATED HILIC ENRICHMENT
#58Enzyme coupled assay for quantification of protein and peptide binding by SAMDI mass spectrometry
#59SOLID PHASE EXTRACTION OF GLOBAL PEPTIDES, GLYCOPEPTIDES, AND GLYCANS USING CHEMICAL IMMOBILIZATION IN A PIPETTE TIP
#60Method for diagnosing cancer through detection of deglycosylation of glycoprotein
#61Inhibitors Of Fatty Acid Amide Hydrolase And Monoacylglycerol Lipase For Modulation Of Cannabinoid Receptors
#62Modulators for SIRT6 and assays for screening same
#63MONITORING AND ASSESSING DEACETYLASE ENZYME ACTIVITY
#64Lamin A, an activator of longevity/anti-aging SIRT1 protein
#65Compounds, substrates and methods related to histone deacetylases
#66Nanoelectronic-enzyme linked immunosorbent assay system and method
#67COMPOSITIONS AND METHODS FOR DETECTION OF A TARGET IN A MOLECULAR ASSAY USING PH CHANGES
#68Novel Polypeptides Having Endolysin Activity and Uses Thereof
#69Use of ACY-1 as a marker of ischaemia/reperfusion, delayed graft function and graft viability as well as method thereof
#70TARGETING GLUTAMINE METABOLISM IN BRAIN TUMORS
#71Labeled glutaminase proteins, isolated glutaminase protein mutants, methods of use, and kit
#72METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#73Fluorescent Chemical Dye for Visualization of Neural Stem Cell Symmetric and Asymmetric Division
#74Methods and reagents for glycoproteomics
#75DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION
#76Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same
#77PGLYRP2 biomarker in idiopathic pneumonia syndrome
#78Methods and kits for detection of O-GlcNAc and N-GlcNAc modification of peptides and proteins
#79Screening method
#80HISTONE DEACETYLASE (HDAC) BIOMARKERS IN MULTIPLE MYELOMA
#81Fluorescent substrates for determining lysine modifying enzyme activity
#82Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
#83MICROFLUIDIC HPLC-CHIP FOR GLYCOPEPTIDE ANALYSIS WITH INTEGRATED HILIC ENRICHMENT
#84Modulators for SIRT6 and assays for screening same
#85Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
#86Compounds and methods for detection of enzymes that remove formyl, succinyl, methyl succinyl or myristoyl groups from ε-amino lysine moieties
#87METHODS AND KITS FOR MEASURING ENZYME ACTIVITY
#88Biotinidase assay
#89Carbonylamino-derivatives as novel inhibitors of histone deacetylase
#90Methods for determining protein binding specificity using peptide libraries
#91METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#92DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION
#93ENZYMES AND METHODS FOR HYDROLYSING PHENYLUREAS, CARBAMATES AND ORGANOPHOSPHATES
#94Method for identifying inhibitors of
#95METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#96COMPOSITIONS AND METHODS FOR DETECTING DEACETYLASE ACTIVITY
#97SIRT1 Modulation of Adipogenesis and Adipose Function
#98Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
#99Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
#100HDAC REGULATION ASSAYS, COMPOUNDS AND THERAPEUTIC COMPOSITIONS
#101Novel Polypeptides Having Endolysin Activity and Uses Thereof
#102METHODS OF IDENTIFYING HISTONE DEACETYLASE INHIBITORS USEFUL FOR NEUROLOGICAL DISORDERS
#103SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY
#104METHOD AND KIT FOR DETERMINING SIRTUIN MODULATING AGENTS, SIRTUIN MODULATING PROCEDURE, SIRTUIN MODULATING COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME
#105Nanoelectronic-enzyme linked immunosorbent assay system and method
#106Biomarkers for chronic vascular dysfunction
#107Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer
#108Tyrosine phosphorylation sites
#109Crystal structure of the catalytic domain of the viral restriction factor APOBEC3G
#110METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#111Depsipeptides and their therapeutic use
#112Screening method
#113Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancer
#114Mass spectrometry assays for identifying compounds that activate deacetylases
#115Carbonylamino-derivatives as novel inhibitors of histone deacetylase
#116Methods of modulating tubulin deacetylast activity
#117Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity
#118SPECTROPHOTOMETRIC ASSAY FOR HUMAN HISTONE DEACETYLASE 8
#119CLASS II HISTONE DEACETYLASE WHOLE CELL ENZYME ASSAY
#120Acid ceramidase and mammalian cell survival
#121Cognitive performance with sirtuin activators
#122METHODS AND COMPOSITIONS FOR DETECTING ENZYMATIC ACTIVITY
#123Methods for extending the replicative lifespan of cells
#124Assays for identifying inhibitors of fatty acid amide hydrolase
#125Assay for determining the activity of fatty acid amide hydrolase
#126Lces as modifiers of the p53 pathway and methods of use
#127Methods for determining protein binding specificity using peptide libraries
#128Computational knowledge model to discover molecular causes and treatment of diabetes mellitus
#129Bindingzyme arrays and high-throughput proteomic methods
#130Proteins and methods useful for assessing risk of cardiovascular disease
#131Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity
#132Array biosensor and method of using same for detecting the concentration of one or more analytes in one or more biological samples
#133Mammalian agmatinase inhibitory substance
#134Carbonylamino-derivatives as novel inhibitors of histone deacetylase
#135SIRT1 modulation of adipogenesis and adipose function